publication venue for
- Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma. 2017
- Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. 2009
- The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.. 10. 2013
- Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model.. 10. 2012
- Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.. 10. 2012
- Interstitial infusion of erlotinib in the rodent brain.. 8. 2009
- Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.. 7. 2008
- Characterization of polyclonal antibodies raised against a linear peptide determinant of desmoglein-3.. 5. 2005
- EGFR inhibitor-mediated apoptosis in solid tumors. 2007
- Gene therapy in cancer: the missing point. 2005